|
🐜
|
Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer.
10 auth.
H. Iguchi,
Kokichi Sugano,
N. Fukayama,
H. Ohkura,
K. Sadamoto,
K. Ohkoshi,
...
Y. Seo,
H. Tomoda,
Akihiro Funakoshi,
H. Wakasugi
|
6 |
1996 |
6
🐜
|
|
🐢
|
A clinicopathological study of asymptomatic gastric cancer.
A. Matsukuma,
M. Furusawa,
H. Tomoda,
Y. Seo
|
5 |
1996 |
5
🐢
|
|
🐬
|
Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease
T. Ezaki,
Y. Seo,
H. Tomoda,
M. Furusawa,
Takashi Kanematsu,
K. Sugimachi
|
5 |
1992 |
5
🐬
|
|
🐜
|
Diffuse bone metastasis with hematologic disorders from gastric cancer: clinicopathological features and prognosis.
8 auth.
T. Etoh,
H. Baba,
A. Taketomi,
H. Nakashima,
S. Kohnoe,
Y. Seo,
...
T. Fukuda,
H. Tomoda
|
5 |
1999 |
5
🐜
|
|
🐢
|
Difference in cytotoxicity of paclitaxel against neoplastic and normal cells.
H. Matsuoka,
M. Furusawa,
H. Tomoda,
Y. Seo
|
5 |
1994 |
5
🐢
|
|
🐢
|
Evaluation of intraoperative radiotherapy for carcinoma of the pancreas: prognostic factors and survival analyses.
10 auth.
A. Nishimura,
S. Sakata,
K. Iida,
Y. Iwasaki,
T. Takeshima,
T. Todoroki,
...
K. Ohara,
K. Hata,
M. Miyoshi,
Y. Seo
|
4 |
1988 |
4
🐢
|
|
🐜
|
Cytotoxicity of CPT-11 for gastrointestinal cancer cells cultured on fixed-contact-sensitive plates.
7 auth.
H. Matsuoka,
K. Yano,
Y. Seo,
T. Saito,
H. Tomoda,
S. Takiguchi,
...
A. Kono
|
3 |
1995 |
3
🐜
|
|
🐬
|
Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.
H. Matsuoka,
K. Yano,
Y. Seo,
T. Saito,
H. Tomoda,
S. Tsurumoto
|
3 |
1995 |
3
🐬
|
